CARDIFF ONCOLOGY INC (CRDF)
US14147L1089 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to CRDF. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.71. This target is 156.22% above the current price.
CRDF was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about CRDF.
In the previous month the buy percentage consensus was at a similar level.
CRDF was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-01 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-08-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-09 | HC Wainwright & Co. | Maintains | Buy |
| 2023-03-29 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-07 | HC Wainwright & Co. | Maintains | Buy |
| 2022-09-16 | HC Wainwright & Co. | Maintains | Buy |
| 2022-09-13 | Piper Sandler | Maintains | Overweight |
| 2022-08-29 | Baird | Maintains | Outperform |
| 2022-05-09 | HC Wainwright & Co. | Maintains | Buy |
| 2022-02-28 | HC Wainwright & Co. | Maintains | Buy |
| 2021-12-08 | Baird | Initiate | Outperform |
| 2021-08-10 | HC Wainwright & Co. | Maintains | Buy |
| 2021-05-10 | HC Wainwright & Co. | Maintains | Buy |